Clinical Trial Update: The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants [NA]

View source ↗

Summary

This update reports a completed trial investigating whether B-type natriuretic peptide can predict the closure of patent ductus arteriosus in premature infants …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: University of Virginia | Conditions: Indomethacin Therapy, Patent Ductus Arteriosus | NA | Status: COMPLETED